USANA Health Sciences (USNA) Tops Q1 EPS by 40c, Revenues Beat; Offers FY20 EPS/Revenue Mid-Point Guidance Above Consensus

Go back to USANA Health Sciences (USNA) Tops Q1 EPS by 40c, Revenues Beat; Offers FY20 EPS/Revenue Mid-Point Guidance Above Consensus
USANA HEALTH SCIENCES, Inc. (NYSE: USNA) Delayed: 13.63 -1.24 (8.34%)
Previous Close $14.87    52 Week High $150.00 
Open $12.69    52 Week Low $92.00 
Day High $14.39    P/E 2.45 
Day Low $12.68    EPS $5.56 
Volume 85,750